The Lancet container_sn27gkxlkbhuzeexoqyapc756a

Published by Elsevier

Search Releases from this Container

Example Publications

Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019

Marissa B Reitsma, Parkes J Kendrick, Emad Ababneh, Cristiana Abbafati, Mohsen Abbasi-Kangevari, Amir Abdoli, Aidin Abedi, E S Abhilash, Derrick Bary Abila, Victor Aboyans, Niveen ME Abu-Rmeileh, Oladimeji M Adebayo (+474 others)
2021 | The Lancet
doi:10.1016/s0140-6736(21)01169-7   pmid:34051883  

Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): a multicentre, prospective, observational cohort study

Bruce M Biccard, Pragasan Dean Gopalan, Malcolm Miller, William Lance Michell, David Thomson, Adesoji Ademuyiwa, Ernest Aniteye, Greg Calligaro, Maman Sani Chaibou, Hailu Tamiru Dhufera, Mohamed Elfagieh, Mahmoud Elfiky (+220 others)
2021 | The Lancet
doi:10.1016/s0140-6736(21)00441-4   pmid:34022988  

Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

Usha Menon, Aleksandra Gentry-Maharaj, Matthew Burnell, Naveena Singh, Andy Ryan, Chloe Karpinskyj, Giulia Carlino, Julie Taylor, Susan K Massingham, Maria Raikou, Jatinderpal K Kalsi, Robert Woolas (+17 others)
2021 | The Lancet
doi:10.1016/s0140-6736(21)00731-5   pmid:33991479  

Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis

Amanda Adler, Larry Agodoa, Ale Algra, Folkert W Asselbergs, Nigel S Beckett, Eivind Berge, Henry Black, Frank P J Brouwers, Morris Brown, Christopher J Bulpitt, Robert P Byington, John Chalmers (+79 others)
2021 | The Lancet
doi:10.1016/s0140-6736(21)00590-0   pmid:33933205  

The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

Anthony Marson, Girvan Burnside, Richard Appleton, Dave Smith, John Paul Leach, Graeme Sills, Catrin Tudur-Smith, Catrin Plumpton, Dyfrig A Hughes, Paula Williamson, Gus A Baker, Silviya Balabanova (+123 others)
2021 | The Lancet
doi:10.1016/s0140-6736(21)00247-6   pmid:33838757  
Known Releases
Preservation Status
205,492 preserved and accessble (bright)
283,908 preserved, inaccessible (dark)
319 no known preservation
Work Types
article-journal 478,384
editorial 4,941
letter 4,608
book 1,439
Unknown 344
interview 3
ISSN-L?  0140-6736
Print:  0140-6736
Electronic:  1474-547X
Wikidata  Q939416
Directory Listings
Not in DOAJ
In Keepers Registery
SHERPA/RoMEO color: green
Preservation Holdings
CLOCKSS: years 1823-2020
HathiTrust: years 1824-1922, 1946-1946, 1948-1952, 1954-1966
Portico: years 1823-2020
Lookup Links
ISSN Portal
The Keepers Registry (preservation)
SHERPA/RoMEO (access policies)
Catalog Record
Revision: c941f962-325a-43bb-9fcf-7b4c3a89a90d